93K
$1B
87K$1B
73K$1B
78K$1B
93K$1B
36K$1B
46K$1B
102K$1B
54K$1B
15K$1B
103K$1BOncolytics Biotech Inc. uses 8 technology products and services including Google Ads, Linkedin Insight Tag, jQuery CDN, and more. Explore Oncolytics Biotech Inc.'s tech stack below.
| Oncolytics Biotech Inc. Email Formats | Percentage |
| FLast@oncolytics.ca | 72% |
| FirstL@oncolytics.ca | 19% |
| Last@oncolytics.ca | 3% |
| FirstLast@oncolytics.ca | 4% |
| First.Last@oncolytics.ca | 2% |
| First.Last@oncolyticsbiotech.com | 50% |
| First.Last@oncolyticsbiotech.com | 50% |
Biotechnology ResearchAlberta, Canada11-50 Employees
Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments.
Company Overview
Media & News
Funding & FinancialsOncolytics Biotech Inc. has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Sep 26, 2023 in the amount of $5M.
Funding & FinancialsOncolytics Biotech Inc. has raised a total of $5M of funding over 7 rounds. Their latest funding round was raised on Sep 26, 2023 in the amount of $5M.
1-888-653-2347 
support@leadiq.com